Rotem Inc.

Topsfield, MA

UEI
GC1PKK5NN1P1
CAGE
3ELW9
Primary NAICS
325411 Medicinal and Botanical Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Foreign Owned
  • For Profit Organization
  • Hospital
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
461 Boston St D4, Topsfield, MA 01983, USA
Founded
1982
Employees
51-250
Estimated annual revenue
$10M-$50M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $19,645
FY2025 $0
FY2024 $19,800
FY2023 $19,800

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Health and Human Services $19,645

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Rotem Inc., a foreign-owned Israeli manufacturer based in Topsfield, Massachusetts, supplies high-purity oxygen-18 enriched water and specialized isotope products to federal health agencies as a prime contractor exclusively—no subcontract work, no IDVs. The vendor competes in full-and-open federal procurement with no set-aside designations across all 28 awards in its federal footprint.

Rotem's customer base concentrates sharply on health and medicine programs. The top five funding agencies account for 82% of recent awards by count and 89% by potential value, anchored by the National Institutes of Health Clinical Center (9 awards, $153 thousand combined potential value) and the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (7 awards, $131 thousand combined potential value), with secondary work at the NIH Office of the Chief Operating Officer, the NIH, and the Department of the Army. The two rankings align closely—NIH Clinical Center leads both volume and dollars. Rotem's capability portfolio tracks to isotope manufacturing and medical-nuclear supply: oxygen-18 enriched water in 50-gram vials (>98% purity) for positron emission tomography radiopharmaceutical production dominates the award record, with related work in medicinal botanical manufacturing, surgical and medical instruments, and pharmaceutical preparation. Representative work includes recurring annual purchase orders with NIH Clinical Center from 2022 through 2026, each valued at $19,800 and carrying ultimate completion dates between twelve and twenty months out; a $19,800 order awarded February 2023 and completed August 2023; and work under Blanket Purchase Agreements 263MD306562 and 263MM308105.

Activity has remained flat at one award per year across 2021–2024, with a single award in 2026. One award ($20 thousand) completes in the next twenty-four months. The vendor's federal footprint reflects a narrow, specialized role: federal registration since 2003 yields twenty-eight awards totaling $424 thousand in potential value across twenty-three years, with obligated dollars reaching $687 thousand—indicating repeat purchase orders on standing agreements rather than large contracts.

Quick answers

Is Rotem Inc. registered in SAM.gov?

Yes. Rotem Inc.'s SAM.gov registration is active through March 9, 2027.

How much has Rotem Inc. received in federal contracts?

Federal contracts obligated $59,245 to Rotem Inc. in fiscal years 2023 through 2027.

What is Rotem Inc.'s most recent federal award?

Rotem Inc.'s most recent federal contract award is Rotem INC.:1240202 [26-001605] (75N90026P00076), from NIH Clinical Center, on January 28, 2026.

On GovTribe

See Rotem Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors